Higher Nicotine Pouch Use Among US Soldiers Revealed

Jan.13
Higher Nicotine Pouch Use Among US Soldiers Revealed
A new study by 29News on Jan 9 shows US soldiers are ten times more likely to use nicotine pouches like ZYN than civilians.

According to a report from 29News on January 9th, a recent study has shown that American soldiers are ten times more likely to use nicotine pouches like ZYN compared to the general population.


A survey conducted at the largest military base in the United States, Fort Bragg, found that 23.8% of service members reported using nicotine pouches at least once in the past 10 days. In contrast, a study of American adults in 2022 found that only 2.9% had used them in the same time period.


The study's co-author, Melissa Little, director of the Nicotine and Tobacco Research Center at the University of Virginia, pointed out that these nicotine pouches are not regulated by the FDA like tobacco products. While some believe that synthetic nicotine may be safer than tobacco, doctors warn that it is too early to draw any conclusions.


Littrell stated that addiction is more common among young and white male soldiers. Despite nicotine and tobacco use historically being a part of military culture, these nicotine pouches are particularly difficult to regulate.


Unlike cigarettes, soldiers can use these nicotine pouches anytime in the field and during training. Littrell says she is not against soldiers choosing to use nicotine pouches, but she hopes they can fully understand the health information and potential risks. She points out that it will take time to determine the specific extent of these risks.


For public health professionals, solving this issue will be particularly challenging, especially among young people and military personnel.


We welcome news tips, article submissions, interview requests, or comments on this piece.

Please contact us at info@2firsts.com, or reach out to Alan Zhao, CEO of 2Firsts, on LinkedIn


Notice

1.  This article is intended solely for professional research purposes related to industry, technology, and policy. Any references to brands or products are made purely for objective description and do not constitute any form of endorsement, recommendation, or promotion by 2Firsts.

2.  The use of nicotine-containing products — including, but not limited to, cigarettes, e-cigarettes, nicotine pouchand heated tobacco products — carries significant health risks. Users are responsible for complying with all applicable laws and regulations in their respective jurisdictions.

3.  This article is not intended to serve as the basis for any investment decisions or financial advice. 2Firsts assumes no direct or indirect liability for any inaccuracies or errors in the content.

4.  Access to this article is strictly prohibited for individuals below the legal age in their jurisdiction.

 

Copyright

 

This article is either an original work created by 2Firsts or a reproduction from third-party sources with proper attribution. All copyrights and usage rights belong to 2Firsts or the original content provider. Unauthorized reproduction, distribution, or any other form of unauthorized use by any individual or organization is strictly prohibited. Violators will be held legally accountable.

For copyright-related inquiries, please contact: info@2firsts.com

 

AI Assistance Disclaimer

 

This article may have been enhanced using AI tools to improve translation and editorial efficiency. However, due to technical limitations, inaccuracies may occur. Readers are encouraged to refer to the cited sources for the most accurate information.

We welcome any corrections or feedback. Please contact us at: info@2firsts.com

Company | Imperial Brands CEO: Expects double-digit NGP growth over the next five years; ZONE nicotine pouches reach ~3% share in the U.S.
Company | Imperial Brands CEO: Expects double-digit NGP growth over the next five years; ZONE nicotine pouches reach ~3% share in the U.S.
At the Barclays Global Consumer Staples Conference, the CEO of Imperial Brands outlined the company’s 2025–2030 strategy and direction for its Next-Generation Products (NGP). He said the NGP business has been “reset,” delivering double-digit growth over the past two years, with the aim of sustaining this pace for the next five years. In response to disposable-vape bans in the UK and France, the company has completed a pivot to rechargeable pod systems, doubling its UK market share and surpassing
Sep.12 by 2FIRSTS.ai
InterTabac 2025 HNB Roundup: New Releases from China Tobacco Hunan, CFU, iMiracle and Others
InterTabac 2025 HNB Roundup: New Releases from China Tobacco Hunan, CFU, iMiracle and Others
At InterTabac 2025, multiple companies unveiled new heated tobacco (HTP/HNB) devices. China Tobacco Hunan introduced Usonic Dual featuring a full-range vortex thermal field and an AI voice assistant; CFU Group launched Biheat with a dual-heating system and a 3.42-inch display; REJO rolled out MULTI, supporting multi-brand sticks with dual heating; UWOO debuted UWOO DH, whose dual stick-slots enable “one stick, two sessions.”
Sep.26 by 2FIRSTS.ai
South Korean Parliament advances revision of tobacco law to include synthetic nicotine products, expected to generate $6.3 billion in tax revenue
South Korean Parliament advances revision of tobacco law to include synthetic nicotine products, expected to generate $6.3 billion in tax revenue
South Korean Parliament advances tobacco law revision, including synthetic nicotine products, anticipating $630 million tax revenue increase.
Oct.16 by 2FIRSTS.ai
Product | Magnetic-attach design + mini display: FASTA’s new product goes on sale in the U.S., priced around $16
Product | Magnetic-attach design + mini display: FASTA’s new product goes on sale in the U.S., priced around $16
FASTA’s 40K Kit hits U.S. retailers: magnetic prefilled pods + reusable battery, mini display, two power levels; rated 20 mL/40,000 puffs/50 mg; some listings at $15.99.
Oct.15 by 2FIRSTS.ai
Reuters: The US FDA, under pressure from the White House, will complete its review of nicotine pouches such as ZYN, VELO, and on! by the end of December
Reuters: The US FDA, under pressure from the White House, will complete its review of nicotine pouches such as ZYN, VELO, and on! by the end of December
The U.S. FDA will launch a pilot program to accelerate reviews of nicotine pouch products from Philip Morris International, Altria, BAT’s Reynolds American, and Turning Point Brands, aiming to complete the process by December 2025. The move, driven by pressure from the Trump administration, seeks to address past multi-year approval delays. Nicotine pouches, the fastest-growing U.S. smoking alternative, are seen as lower-risk but raise youth appeal concerns.
Sep.08
France’s Finance Committee Rejects 2026 Vaping Tax, Backs Online Sales Ban
France’s Finance Committee Rejects 2026 Vaping Tax, Backs Online Sales Ban
France’s National Assembly Finance Committee voted to oppose the government’s plan in Article 23 of the 2026 budget bill to tax vaping products at €0.30/10mL for low-nicotine liquids and €0.50/10mL for others (with typical bottles priced €5–€7). Lawmakers arguing against the tax said vaping is less harmful than combustible cigarettes and can aid cessation; others warned of a gateway effect for youth and sustained nicotine dependence.
Oct.23 by 2FIRSTS.ai